Population and Public Health

Are ACA Benefits Driving Up the Cost of American Healthcare?
Business Are ACA Benefits Driving Up the Cost of American Healthcare?

As the American healthcare landscape navigates the complexities of 2026, the expiration of pandemic-era financial cushions has thrust the Affordable Care Act back into the center of a high-stakes national debate over whether mandated benefits are truly sustainable. The political and economic

Can Nadia Care’s Hybrid Model Fix the Maternal Health Crisis?
Care Can Nadia Care’s Hybrid Model Fix the Maternal Health Crisis?

As the CEO of Nadia Care, Adaeze Enekwechi is tackling the maternal health crisis by bridging the gap between clinical requirements and the lived experiences of mothers. With the United States facing some of the highest maternal mortality rates among high-income nations, her approach focuses on

Why Should Clinical Trials Move to Digital Recruitment?
Technology Why Should Clinical Trials Move to Digital Recruitment?

Suzanne Harris is a veteran patient advocate and the Senior Vice President of Marketing & Communications at SubjectWell, where she spearheads initiatives to modernize the intersection of clinical research and patient engagement. With a deep focus on patient-centric solutions, she has become a

Spain Guarantees Free Healthcare for Undocumented Migrants
Public Policy Spain Guarantees Free Healthcare for Undocumented Migrants

The foundational belief that medical assistance should be a fundamental human right rather than a privilege reserved for those with legal residency papers has long defined the Spanish social contract. While many nations struggle with the complexities of managing growing migrant populations, Spain

Generative AI vs. Clinical Reasoning Systems: A Comparative Analysis
Technology Generative AI vs. Clinical Reasoning Systems: A Comparative Analysis

The high-stakes environment of a modern hospital requires a level of precision where the margin for error is nonexistent and a single misinterpreted data point can alter a patient's life forever. Within this complex landscape, a fundamental tension has emerged between the seductive ease of

Can Vima Therapeutics Change How We Treat Movement Disorders?
Care Can Vima Therapeutics Change How We Treat Movement Disorders?

The global biotechnology sector is currently navigating a pivotal transition as companies move beyond traditional dopamine-replacement therapies to explore more sophisticated neurological pathways. This shift is most visible in the recent strategic expansion of Vima Therapeutics, a Cambridge-based

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later